NCT04422600View on ClinicalTrials.gov

Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

August 1, 2023

Conditions
Fetal Exposure Timing Unspecified
Interventions
OTHER

There is no other intervention, only clinical treatment.

The investigators will then correlate that exposure with neurodevelopmental outcomes.

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT04422600 - Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects | Biotech Hunter | Biotech Hunter